1 Moore RA Derry S . Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis. Arthritis Res Ther2006; 8: R182.
2.
2 Ginzler EM Dooley MA Aranow C . Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med2005; 353: 2219–2228.
3.
3 Esdaile JM Joseph L Abrahamowicz M Li Y Danoff D Clarke AE . Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies. J Rheumatol1996; 23: 1891–1896.
4.
4 Rovin BH Birmingham DJ Nagaraja HN Yu CY Hebert LA . Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis2007; 65: 187–193.
5.
5 Potlukova E Kralikova P . Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Scand J Immunol2008; 67: 423–430.
6.
6 Jacobi AM Odendahl M Reiter K . Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum2003; 48: 1332–1342.
7.
7 Biesen R Demir C Barkhudarova F . Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum2008; 58: 1136–1145.
8.
8 Brentjens JR Sepulveda M Baliah T . Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int1975; 7: 342–350.
9.
9 Jeruc J Jurcic V Vizjak A . Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis. Wien Klin Wochenschr2000; 112: 702–706.
10.
10 Perez de Lema G Maier H . Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol2001; 12: 1369–1382.
11.
11 Avihingsanon Y Phumesin P Benjachat T . Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Kidney Int2006; 69: 747–753.
12.
12 Chan RW Lai FM Li EK . Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum2004; 50: 2882–2890.
13.
13 Rovin BH Song H Birmingham DJ Hebert LA Yu CY Nagaraja HN . Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol2005; 16: 467–473.
14.
14 Li Y Tucci M Narain S . Urinary biomarkers in lupus nephritis. Autoimmun Rev2006; 5: 383–388.
15.
15 Schwartz N Su L Burkly LC . Urinary TWEAK and the activity of lupus nephritis. J Autoimmun2006; 27: 242–250.
16.
16 Chan RW Tam LS Li EK . Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis. Arthritis Rheum2003; 48: 1326–1331.
17.
17 Chan RW Lai FM Li EK . Urinary mononuclear cell and disease activity of systemic lupus erythematosus. Lupus2006; 15: 262–267.
18.
18 Pitashny M Schwartz N Qing X . Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum2007; 56: 1894–1903.
19.
19 Wu T Xie C Wang HW . Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol2007; 179: 7166–7175.
20.
20 Noris M Bernasconi S Casiraghi F . Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest1995; 73: 804–809.
21.
21 Wada T Yokoyama H Su SB . Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int1996; 49: 761–767.
22.
22 Tesch GH Maifert S Schwarting A Rollins BJ Kelley VR . Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med1999; 190: 1813–1824.
23.
23 Enghard P Humrich JY Rudolph B . CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in SLE patients. Arthritis Rheum2009; 60: 199–206.
24.
24 Segerer S Banas B Wornle M . CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am J Pathol2004; 164: 635–649.
